Quadruple immunosuppressive therapy for liver transplantation.
Kalayoglu
M
M
Department of Surgery, University of Wisconsin-Madison.
Stratta
R J
RJ
Hoffmann
R M
RM
Sollinger
H W
HW
Belzer
F O
FO
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D000954:Antigens, Surface / Q000276:immunology; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016031:Liver Transplantation; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011183:Postoperative Complications / Q000401:mortality; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D014184:Transplantation, Homologous / Q000401:mortality; D014922:Wisconsin
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone